We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microchip Technology Screens for More Than 1000 Molecules

By LabMedica International staff writers
Posted on 06 Aug 2009
Scientists have developed technology to perform over a thousand chemical reactions at once on a stamp-size, PC-controlled microchip.

The technology, which is based on microfluidics, utilized miniaturized devices to automatically handle and channel tiny amounts of liquids and chemicals invisible to the eye. The chemical reactions were performed using in situ click chemistry, and analyzed using mass spectrometry.

A thousand cycles of complex processes, including controlled sampling and mixing of a library of reagents and sequential microchannel rinsing, all took place on the microchip device and were completed in a few hours. Developed by a University of California, Los Angeles (UCLA; Los Angeles, CA, USA) team, the technology is restricted to analyzing the reaction results offline, but the aim is to automate this aspect of the work also. It could accelerate the identification of potential drug candidates for treating diseases like cancer.

The team intends to utilize the technology for diagnostic screening reactions in which chemicals and material samples are in limited supply; e.g., protein enzymes such as kinases that play critical roles in the malignant transformation of cancer. According to the scientists, the technology will open up many areas for biologic and medicinal study.

"The precious enzyme molecules required for a single in situ click reaction in a traditional lab now can be split into hundreds of duplicates for performing hundreds of reactions in parallel, thus revolutionizing the laboratory process, reducing reagent consumption and accelerating the process for identifying potential drug candidates," said study author Prof. Hsian-Rong Tseng, scientist at UCLA's Crump Institute for Molecular Imaging, associate professor molecular and medical pharmacology at the David Geffen School of Medicine at UCLA, and a member of the California NanoSystems Institute at UCLA.

The Study appeared online in the August 2009 edition of Science Daily.

Related Links:
University of California, Los Angeles
Science Daily


Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
EBV DNA Quantitative Fluorescence Diagnostic Kit
S3015E EBV
New
Hematocrit Centrifuge
4088M1 - Zip Compact

Latest Clinical Chem. News

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability